Literature DB >> 11123398

Hyperkalaemic quadriparesis secondary to chronic diclofenac treatment.

P Patel1, B Mandal, M W Greenway.   

Abstract

A 76 year old woman presented with a quadriparesis associated with hyperkalaemia. She had a 10 month history of treatment with oral diclofenac sodium. On admission she had hyperkalaemic metabolic acidosis with a normal anion gap and mild renal impairment. Her weakness resolved after withdrawal of diclofenac and medical correction of her hyperkalaemia. Non-steroidal anti-inflammatory drugs are known to cause hyperkalaemic acidosis and should be used with caution, especially in the presence of renal impairment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11123398      PMCID: PMC1741869          DOI: 10.1136/pmj.77.903.50

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Risk of hyperkalemia associated with selective COX-2 inhibitors.

Authors:  Hisham Aljadhey; Wanzhu Tu; Richard A Hansen; Susan Blalock; D Craig Brater; Michael D Murray
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-11       Impact factor: 2.890

2.  The association between nonsteroidal anti-inflammatory drugs and potassium concentrations: A pharmacoepidemiological study in Saudi Arabia.

Authors:  Hisham Aljadhey
Journal:  Saudi Pharm J       Date:  2011-08-23       Impact factor: 4.330

3.  Post-operative hyperkalaemic paralysis.

Authors:  G C Beattie; G V McDonnell; A J Wilkinson; R J Maxwell
Journal:  Ulster Med J       Date:  2003-05

4.  A case of acute paraplegia that improved with dialysis.

Authors:  Govarthanan Rajendiran; Rajamahesh Jayabalan; Saravanan Chandrahasan; Ashwin Kumar Mani
Journal:  Indian J Crit Care Med       Date:  2008-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.